Oxford University scientists have developed a diagnostic test capable of detecting the SARS-CoV-2 virus in five minutes. The test can differentiate between and negative samples or other respiratory pathogens such as influenza. It works directly on the throat swabs from Covid-19 patients, and quickly labels the virus particles on the sample with the help of fluorescent DNA strips.
Genalyte, a healthcare analytics and diagnostics company, has obtained Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its SARS-CoV-2 multi-antigen serology panel. The test identifies IgG and IgM antibodies produced by the body to fight the SARS-CoV-2 virus. The panel, along with the FDA-approved Maverick™ Diagnostic System, is expected to improve antibody testing and deliver accurate results in 20 minutes.
Go deeper with GlobalData
bioLytical Laboratories, an HIV diagnostic products company, has launched a one-minute antibody test for Covid-19 in Europe after receiving CE mark approval. The test uses flow-through technology to deliver fast results. bioLytical aims to start manufacturing of the new test kits and rapidly distribute them across the globe.
Chembio Diagnostics, a diagnostic company, has submitted an Emergency Use Authorisation (EUA) application for the DPP SARS-CoV-2 antigen test system to the FDA. The test system can detect SARS-CoV-2 antigens in 20 minutes and includes an antigen test cartridge, a nasal swab, and a micro reader optical analyser.
